当前位置:首页 - 行情中心 - 九洲药业(603456) - 财务分析

九洲药业

(603456)

  

流通市值:140.28亿  总市值:140.28亿
流通股本:8.95亿   总股本:8.95亿

九洲药业(603456)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润6.33亿元,每股收益0.70元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益862307.65万元,未分配利润307868.71万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1100858.11万元,负债238550.46万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入3,965,261,223.172,764,279,820.311,475,743,576.445,523,418,175.43
营业总成本3,190,787,304.912,176,923,770.531,168,180,070.264,275,834,833.86
营业利润747,100,077.02554,674,434.85280,086,558.721,175,771,384.98
利润总额746,709,777.94554,870,663.04280,042,041.461,180,642,037.57
净利润632,852,491.81475,613,557.25236,172,887.541,031,371,775.69
其他综合收益-3,871,050.781,710,782.562,362,921.592,052,331.71
综合收益总额628,981,441.03477,324,339.81238,535,809.131,033,424,107.4
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计6,146,016,362.816,376,944,547.477,636,556,912.136,314,388,178.72
非流动资产合计4,862,564,715.654,744,301,110.774,613,249,505.524,537,599,177.97
资产总计11,008,581,078.4611,121,245,658.2412,249,806,417.6510,851,987,356.69
流动负债合计1,685,338,427.271,927,552,669.082,816,696,213.531,656,620,008.06
非流动负债合计700,166,139.58725,424,222.43697,307,978.84662,296,455.42
负债合计2,385,504,566.852,652,976,891.513,514,004,192.372,318,916,463.48
归属于母公司股东权益合计8,549,162,888.638,395,706,012.928,664,450,376.148,461,133,056.22
股东权益合计8,623,076,511.618,468,268,766.738,735,802,225.288,533,070,893.21
负债和股东权益合计11,008,581,078.4611,121,245,658.2412,249,806,417.6510,851,987,356.69
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计3,947,477,914.322,589,014,907.29992,823,527.785,405,224,774.92
经营活动现金流出小计3,293,449,736.712,269,490,807.61,129,288,199.414,044,900,844.53
经营活动产生的现金流量净额654,028,177.61319,524,099.69-136,464,671.631,360,323,930.39
投资活动现金流入小计11,352,517.63502,856282,18129,744,871.59
投资活动现金流出小计758,490,718.64495,007,463.87233,987,147.261,086,548,270.82
投资活动产生的现金流量净额-747,138,201.01-494,504,607.87-233,704,966.26-1,056,803,399.23
筹资活动现金流入小计1,627,052,534.161,571,949,063.231,548,800,0004,603,559,971.42
筹资活动现金流出小计2,104,835,992.351,654,745,732.79596,294,398.332,501,374,630.93
筹资活动产生的现金流量净额-477,783,458.19-82,796,669.56952,505,601.672,102,185,340.49
汇率变动对现金及现金等价物的影响-6,884,895.395,376,453.08700,482.377,604,699.48
现金及现金等价物净增加额-577,778,376.98-252,400,724.66583,036,446.152,413,310,571.13
期末现金及现金等价物余额2,498,290,974.922,823,668,627.243,659,105,798.053,076,069,351.9
最新报告期:2024-11-01
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
光大证券王明瑞0.981.101.262024-11-01
中信建投袁清慧,贺菊颖1.131.251.442024-10-29
财通证券张文录0.951.101.152024-10-29
华西证券崔文亮,徐顺利0.921.071.092024-10-28
中金公司张琎1.311.56--2024-10-26
TOP↑